Literature DB >> 10867661

Autoradiographic localization of (125)I[Tyr(14)]orphanin FQ/nociceptin and (125)I[Tyr(10)]orphanin FQ/nociceptin(1-11) binding sites in rat brain.

S R Letchworth1, J P Mathis, G C Rossi, R J Bodnar, G W Pasternak.   

Abstract

The endogenous ligand for the orphan opioid receptor, orphanin FQ/nociceptin (OFQ), has recently been characterized. The OFQ peptide sequence contains paired basic amino acids, suggesting the possibility of posttranslational processing to a peptide containing the first 11 amino acids of the OFQ peptide. This peptide has been reported in the brain and it has a unique pharmacology. In the present study, we compared the autoradiographic distribution of (125)I[Tyr(14)]OFQ and (125)I[Tyr(10)]OFQ(1-11) in coronal rat brain sections. Nonspecific binding was defined with unlabeled OFQ or OFQ(1-11), respectively. Both radioligands demonstrated high levels of specific binding (>95% of total binding), with no appreciable binding in white matter areas with either ligand. (125)I[Tyr(14)]OFQ binding was widely distributed throughout the rat brain. In contrast, (125)I[Tyr(10)]OFQ(1-11) binding was more restricted. The highest (125)I[Tyr(14)]OFQ binding levels measured in this study were found in the locus coeruleus, an area which contained very low (125)I[Tyr(10)]OFQ(1-11) binding. Both ligands labeled the cortex, hippocampus and amygdala. In the thalamus, (125)I[Tyr(14)]OFQ binding was prominent in most nuclei, whereas (125)I[Tyr(10)]OFQ(1-11) binding was restricted to the midline thalamus. (125)I[Tyr(14)]OFQ binding was heavy in the suprachiasmatic hypothalamus, and moderate in other hypothalamic nuclei. (125)I[Tyr(10)]OFQ(1-11) binding in the hypothalamus, however, was present mainly in the ventromedial hypothalamic nucleus. Lower binding levels of both ligands were found in the caudate putamen. The distinct autoradiographic patterns of these two ligands are consistent with different binding sites, which might help explain their different functional activities. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867661

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  10 in total

1.  Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.

Authors:  M K Tallent; S G Madamba; G R Siggins
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  Increased opioid receptor binding and G protein coupling in the accumbens and ventral tegmental area of postnatal day 2 rats.

Authors:  Yanning Hou; Mariana M Belcheva; Amy L Clark; Daniel S Zahm; Carmine J Coscia
Journal:  Neurosci Lett       Date:  2005-11-21       Impact factor: 3.046

3.  Antioscillatory effects of nociceptin/orphanin FQ in synaptic networks of the rat thalamus.

Authors:  Susanne Meis; Thomas Munsch; Hans-Christian Pape
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Effects of stimulation of mu opioid and nociceptin/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys.

Authors:  Shawn M Flynn; Phillip M Epperly; April T Davenport; Gerta Cami-Kobeci; Stephen M Husbands; Mei-Chuan Ko; Paul W Czoty
Journal:  Neuropsychopharmacology       Date:  2019-04-10       Impact factor: 7.853

5.  Nocistatin and nociceptin modulate c-Fos expression in the mice thalamus.

Authors:  Jamil Ahsan Kazi
Journal:  Neurol Sci       Date:  2012-01-13       Impact factor: 3.307

6.  Medial forebrain stimulation enhances intracranial nociception and attenuates morphine analgesia suggesting the existence of an endogenous opioid antagonist.

Authors:  Conan Kornetsky; Clifford M Knapp; Lisa Tozier; Arlene Pak
Journal:  Pharmacol Biochem Behav       Date:  2010-02-10       Impact factor: 3.533

7.  Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography.

Authors:  Victor W Pike; Karen S Rash; Zhaogen Chen; Concepción Pedregal; Michael A Statnick; Yasuyuki Kimura; Jinsoo Hong; Sami S Zoghbi; Masahiro Fujita; Miguel A Toledo; Nuria Diaz; Susan L Gackenheimer; Johannes T Tauscher; Vanessa N Barth; Robert B Innis
Journal:  J Med Chem       Date:  2011-03-25       Impact factor: 7.446

Review 8.  Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.

Authors:  Grace C Rossi; Richard J Bodnar
Journal:  Cell Mol Neurobiol       Date:  2020-09-24       Impact factor: 5.046

Review 9.  Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse.

Authors:  Norikazu Kiguchi; Huiping Ding; Mei-Chuan Ko
Journal:  J Neurosci Res       Date:  2020-04-07       Impact factor: 4.433

10.  NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats.

Authors:  Anna Maria Borruto; Yannick Fotio; Serena Stopponi; Michele Petrella; Sara De Carlo; Ana Domi; Massimo Ubaldi; Friedbert Weiss; Roberto Ciccocioppo
Journal:  Neuropsychopharmacology       Date:  2021-07-20       Impact factor: 7.853

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.